VanEck Biotech ETF Rating $161.23 -3.95 (-2.39%) Closing price 08/5/2025 03:59 PM EasternExtended Trading$161.54 +0.31 (+0.19%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock VanEck Biotech ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBH Aggregate RatingModerate Buy 2.65Holdings in BBH have an aggregate rating of Moderate Buy based on 483 analyst ratings issued in the past year covering 24 companies (100.0% of the portfolio).BBH Aggregate Price Target$161.23High Prediction$161.23Average Prediction$161.23Low Prediction$161.23Holdings in BBH have an aggregate price target of $161.23 and a range of $161.23 to $161.23 covering 24 companies (100.0% of the portfolio).BBH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy12 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 BBH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings16.18%AMGNAmgen$300.08-0.6%4.596 of 5 stars2.35$307.27 2.4%23Trending NewsEarnings ReportDividend Announcement12.65%GILDGilead Sciences$112.46-1.8%4.6536 of 5 stars2.81$112.36 -0.1%26Positive NewsUpcoming Earnings10.43%VRTXVertex Pharmaceuticals$374.98-20.6%4.8898 of 5 stars2.50$495.21 32.1%26Trending NewsEarnings ReportAnalyst ForecastGap DownHigh Trading Volume5.34%IQVIQVIA$183.83+0.6%4.6486 of 5 stars2.74$228.62 24.4%23Positive News5.11%REGNRegeneron Pharmaceuticals$569.90-0.3%4.9106 of 5 stars2.75$832.73 46.1%24Positive NewsEarnings ReportDividend AnnouncementAnalyst Forecast4.83%ARGXargenex$674.90-2.2%4.1275 of 5 stars3.10$746.81 10.7%20Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision4.64%ALNYAlnylam Pharmaceuticals$418.91-0.2%3.9118 of 5 stars2.85$396.04 -5.5%27Trending NewsEarnings ReportAnalyst Upgrade3.99%ICLRIcon$165.98+0.7%4.5217 of 5 stars2.81$219.54 32.3%16Positive News3.57%NTRANatera$140.12+2.6%3.5836 of 5 stars3.06$183.76 31.1%16Upcoming EarningsInsider Trade3.48%INSMInsmed$111.61+0.3%3.7979 of 5 stars3.00$109.20 -2.2%17Upcoming Earnings3.37%BIIBBiogen$132.89+0.5%4.9158 of 5 stars2.34$185.63 39.7%32Trending NewsEarnings ReportAnalyst Revision3.15%ILMNIllumina$97.76-0.7%4.8927 of 5 stars2.40$127.47 30.4%20Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision3.09%ONCBeOne Medicines$307.23+1.0%0.6977 of 5 stars3.00$327.56 6.6%7Insider Trade2.97%BNTXBioNTech$111.07+0.9%2.1897 of 5 stars2.76$135.91 22.4%17Trending NewsEarnings ReportAnalyst ForecastGap Up2.77%NBIXNeurocrine Biosciences$128.39+0.3%4.9667 of 5 stars2.86$160.90 25.3%22Trending NewsEarnings ReportAnalyst Revision2.69%MRNAModerna$27.47-0.6%4.2603 of 5 stars2.04$45.61 66.0%25Trending NewsEarnings ReportAnalyst Forecast1.98%INCYIncyte$77.72-0.4%4.7635 of 5 stars2.28$79.73 2.6%181.87%TECHBio-Techne$54.64-0.4%4.9037 of 5 stars2.62$69.58 27.3%13News CoveragePositive News1.75%CRLCharles River Laboratories International$167.30-0.4%4.3315 of 5 stars2.25$174.54 4.3%16Positive News1.72%QGENQiagen$49.91-0.7%3.323 of 5 stars2.30$49.40 -1.0%10News CoverageEarnings ReportAnalyst Upgrade1.54%BMRNBioMarin Pharmaceutical$61.93+2.7%4.9956 of 5 stars2.74$92.59 49.5%23Trending NewsAnalyst ForecastGap UpHigh Trading Volume1.34%EXASExact Sciences$47.36+1.1%4.4504 of 5 stars2.95$70.50 48.9%22Positive News1.26%RGENRepligen$115.88-0.5%4.7189 of 5 stars2.73$169.45 46.2%110.25%SRPTSarepta Therapeutics$16.75-2.0%4.6275 of 5 stars2.10$49.12 193.3%29 This page (NASDAQ:BBH) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredStrange twist to Bitcoin’s rallyThe #1 crypto to buy today Better than Bitcoin? (top crypto for less than $1) Over the past 15 years, B...Stansberry Research | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
